NYT > Top StoriesA plummet in the company’s valuation and a recent board resignation have raised questions about the future of genetic data collected from millions of customers. Read More
last news of the week
As 23andMe Struggles, Concerns Surface About Its Genetic Data
NYT > Top StoriesA plummet in the company’s valuation and a recent board resignation have raised questions about the future of genetic data collected from millions of customers. Read More
NYT > Top StoriesA plummet in the company’s valuation and a recent board resignation have raised questions about the future of genetic data collected from millions of customers. Read More